Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
Clinical trial NCT04101721 · COMPLETED
Trial details
- NCT number
- NCT04101721
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2022-08-18
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.